Aster DM Quality Care Ltd
NSE: ASTERDM · Hospital · sector
₹647.00NSE close 2026-10-26
Key numbers
Market cap₹33,523 cr
Price₹647.00
52w high / low₹891 / ₹519
P/E104.7xSector median 42.5x
P/B7.3xSector median 4.9x
Book value₹88.3
Dividend yield0.16%Sector median 0.17%
ROE8.0%Sector median 12.1%
ROCE12.8%Sector median 13.8%
OPM16.7%Sector median 20.3%
Debt / equity0.15xSector median 0.24x
EV/EBITDA40.4xSector median 23.6x
Interest cover5.5x
Current ratio1.99x
Sales growth 3y-27.0%Sector median +14.1%
Profit growth 3y-3.0%Sector median +14.7%
PEG–
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 32 companies in Hospital (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹1,327 cr vs borrowings ₹701 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 5.5x in the last 12 months.
- 66.85% of the promoters' shares are pledged (36.0% of all shares).
- Promoter holding rose by 13.40 percentage points in a year, to 53.79% (2026-09-30).
- Operating cash flow was below net profit in 1 of the last 5 years (FY25).
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 41% of net profit in the last 12 months.
- Dividend paid in 2 of the last 5 financial years.
- Price ₹647.00 on 2026-10-26: -27.4% from the 52-week high, +24.6% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹842.10 · low ₹394.00
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,086 | 1,050 | 1,000 | 1,078 | 1,197 | 1,186 | 1,182 | 1,311 |
| EBITDA | 220 | 165 | 166 | 203 | 249 | 183 | 233 | 150 |
| OPM % | 20.2% | 15.8% | 16.6% | 18.8% | 20.8% | 15.4% | 19.7% | 11.4% |
| Other income | 35 | 33 | 31 | 33 | 28 | 28 | 36 | 37 |
| Net profit | 97 | 57 | 79 | 86 | 110 | 52 | 140 | 16 |
| EPS (₹) | 1.94 | 1.14 | 1.59 | 1.67 | 2.13 | 1.02 | 2.72 | 0.31 |
| Revenue YoY | +10.2% | +12.9% | +18.2% | +21.6% | ||||
| Profit YoY | +13.6% | -7.6% | +77.4% | -81.2% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 10,253 | 11,933 | 3,699 | 4,138 | 4,643 | 4,876 |
| EBITDA | 1,483 | 1,565 | 578 | 714 | 868 | 815 |
| Net profit | 526 | 425 | 129 | 5,378 | 388 | 319 |
| EPS (₹) | 10.58 | 8.55 | 2.60 | 107.98 | 7.53 | 6.18 |
| Revenue growth | +16.4% | -69.0% | +11.9% | +12.2% | +15.7% | |
| Profit growth | -19.2% | -69.6% | +4,059.8% | -92.8% | +0.2% | |
| Dividend / share (₹) | – | – | – | 124.00 | 1.00 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | -27.0% | -11.6% | +15.7% |
| Net profit | -3.0% | +21.3% | +0.2% |
| EPS | -4.1% | +20.5% | – |
| Share price | – | +23.2% (2y) | -10.1% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 4,448 | 4,560 | 3,428 | 4,576 |
| Borrowings | – | 2,287 | 669 | 642 | 701 |
| Cash & equivalents | – | 440 | 116 | 1,381 | 1,327 |
| Total assets | – | 14,881 | 17,991 | 6,606 | 8,112 |
| Fixed assets | – | 4,629 | 2,880 | 3,628 | 2,619 |
| Capital work in progress | – | 255 | 170 | 291 | 413 |
| Investments | – | 68 | 14 | 12 | 971 |
| Receivables | – | 2,336 | 233 | 258 | 307 |
| Inventory | – | 1,306 | 111 | 92 | 91 |
| Payables | – | 2,988 | 459 | 426 | 482 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 1,313 | 1,834 | 158 | 425 | 656 |
| Cash from investing | -570 | -972 | -885 | 6,015 | -288 |
| Cash from financing | -685 | -817 | 1,053 | -6,358 | -304 |
| Capex | 548 | 848 | 806 | 357 | 478 |
| Free cash flow | 765 | 986 | -648 | 68 | 178 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 9.6% | 2.8% | 156.9% | 8.5% |
| ROCE % | – | 12.8% | 7.3% | 15.1% | 13.8% |
| Debtor days | – | 71 | 23 | 23 | 24 |
| Inventory days | – | 135 | 44 | 36 | 32 |
| Payable days | – | 309 | 183 | 166 | 168 |
| Cash conversion cycle (days) | – | -103 | -116 | -107 | -112 |
| Working capital days | – | 8 | -30 | 90 | 76 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 53.79% |
| FIIs | 12.26% |
| DIIs | 21.67% |
| of which Mutual funds | 20.76% |
| of which Insurance | 0.67% |
| Government | 0.00% |
| Public (non-institutions) | 12.17% |
| Quarter | Apr 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Jul 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 40.38% | 40.39% | 40.39% | 40.39% | 40.39% | 40.39% | 53.72% | 53.79% |
| Promoter group | % |
|---|---|
| BCP Asia II Topco IV Pte. Ltd | 29.20% |
| Union Investments Private Limited | 21.44% |
| Union (Mauritius) Holdings Limited | 2.87% |
| Azad Moopen Mandayapurath | 0.17% |
| Alisha Moopen | 0.03% |
| Naseera Azad | 0.03% |
| Zeba Azad Moopen | 0.03% |
| Ziham Moopen | 0.02% |
| Public holders above 1% | % |
|---|---|
| Hdfc Small Cap Fund | 7.87% |
| Rimco (Mauritius) Limited | 4.08% |
| Kotak Midcap Fund | 4.06% |
| Centella Mauritius Holdings Limited | 2.18% |
| Sbi Contra Fund | 1.86% |
| Rashid Aslam Bin Mohideen Mammu Haji | 1.29% |
| Quant Mutual Fund - Quant Small Cap Fund | 1.22% |
| M I Sahadulla | 1.21% |
| Smallcap World Fund, Inc | 1.15% |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | 1.06% |
1,35,156 shareholders. Pledged: 66.85% of promoter shares.
Peers in Hospital
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | ₹1,12,797 cr | 54.0x | 11.9x | 23.6% | 21.8% | 15.1% | +14.9% | 0.26% |
| MAXHEALTH | ₹81,266 cr | 55.7x | 7.6x | 14.5% | 13.8% | 26.1% | +22.4% | 0.18% |
| MANIPALHOS | ₹73,581 cr | – | – | – | – | – | – | – |
| FORTIS | ₹55,467 cr | 52.9x | 5.6x | 11.1% | 13.2% | 22.2% | +13.2% | 0.14% |
| NH | ₹33,971 cr | 41.4x | 7.5x | 20.0% | 13.7% | 18.7% | +20.4% | 0.26% |
| ASTERDM | ₹33,523 cr | 104.7x | 7.3x | 8.0% | 12.8% | 16.7% | -27.0% | 0.16% |
| MEDANTA | ₹32,575 cr | 58.5x | 8.2x | 15.1% | 15.8% | 20.5% | +17.9% | 0.04% |
| KIMS | ₹28,123 cr | 131.3x | 12.5x | 9.3% | 9.6% | 19.5% | +21.1% | 0.74% |
| AGARWALEYE | ₹15,065 cr | 101.3x | 7.4x | 7.6% | 16.5% | 27.8% | – | 0.01% |
| RAINBOW | ₹11,802 cr | 41.3x | 7.2x | 18.3% | 27.4% | 31.5% | +13.2% | 0.26% |
Business segments (FY26)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Hospitals & Clinics | ₹4,506 cr | 94.2% | ₹780 cr | 17.3% |
| Labs | ₹154 cr | 3.2% | ₹15 cr | 9.7% |
| Wholesale Pharmacies | ₹108 cr | 2.3% | ₹1 cr | 0.7% |
| Others | ₹15 cr | 0.3% | ₹-17 cr | -114.9% |
| 0 | ₹0 cr | – | ₹0 cr | – |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-04-02 | Dividend | Interim Dividend - Rs 3 Per Share |
| 2025-08-28 | Dividend | Dividend - Re 1 Per Share |
| 2025-02-10 | Dividend | Interim Dividend - Rs 4 Per Share |
| 2024-08-22 | Dividend | Annual General Meeting/Dividend - Rs 2 Per Share |
| 2024-04-23 | Dividend | Special Dividend - Rs 118 Per Share |
| 2020-01-23 | Buyback | Buy Back |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Revenue from hospital and medical services*: Healthcare services through hospitals and clinics
- Revenue from pharmacy: Sale of pharma, non-pharma products and optical
| Sector | Healthcare |
| Industry | Hospital |
| Sub-industry | Hospital |
| Symbol | ASTERDM |
| BSE code | 540975 |
| ISIN | INE914M01019 |
| Face value | ₹10.0 |
| Incorporated | 2008-01-18 |
| Website | www.asterqualitycare.com |
| Plants (India / abroad) | 537 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.